#Lab-on-a-chip and Microarrays(BIOCHIP) Market size
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
When “GIF” was named word of the year in 2012, Oxford Dictionaries U.S.A. credited Tumblr for pushing the word.
Text
Lab-on-a-chip and Microarrays(BIOCHIP) Market: Future Demand, Analysis & Outlook to 2025
The research report on Lab-on-a-chip and Microarrays(BIOCHIP) market as well as industry is an in-depth study that provides detailed information of leading players, qualitative analysis and quantitative analysis, types & end-users; historical figures, region analysis, market technology landscape & restraints, strategic planning, and a precise section for the effect of Covid-19 on the industry. Our research analysts intensively determine the significant outlook of the global Lab-on-a-chip and Microarrays(BIOCHIP) market study with regard to primary research & secondary research and they have represented it in the form of figures, pie charts, tables & other pictorial representations for better understanding.
To Know More Details About This Report, Get Sample @ http://www.acquiremarketresearch.com/sample-request/347739
The report on Lab-on-a-chip and Microarrays(BIOCHIP) market claims this industry to emerge as one of the most lucrative spaces in the ensuing years, exhibiting a modest growth rate over the forecast period. Enumerating a highly exhaustive outline of Lab-on-a-chip and Microarrays(BIOCHIP) Market size, this report is also inclusive of the total valuation that the Lab-on-a-chip and Microarrays(BIOCHIP) industry presently holds, a brief segmentation of this market and Lab-on-a-chip and Microarrays(BIOCHIP) market growth opportunities of this industry in addition to its geographical expanse.
Major Key Players Covered In This Report:
Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Beckman Coulter, Cepheid, Fluidigm, GE Healthcare, Roche Holding, Illumina, Biomerieux, Thermo Fisher Scientific, PerkinElmer
Lab-on-a-chip and Microarrays(BIOCHIP) Market Analysis by 2020
This research report based on ‘Lab-on-a-chip and Microarrays(BIOCHIP) market’ and available with Acquire Market Research includes latest and upcoming market trends in addition to the global spectrum of the ‘Lab-on-a-chip and Microarrays(BIOCHIP) market’ that includes numerous regions. Moreover, the research also expands on intricate details pertaining to contributions by key Manufacturers, import & export, demand and supply analysis as well as industry size, share growth of the Lab-on-a-chip and Microarrays(BIOCHIP) industry.
The specified segments and sub-sections of the market are explained below:
By Product Type:
DNA Microarrays, Microfluidics
By Application/End-user:
Genomics, Proteomics, Cell Assays, Clinical Diagnostics, Drug Discovery, Other
By country/region:
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Check Discount @ http://www.acquiremarketresearch.com/discount-request/347739
Frequently Asked Questions About This Market Research Report:
What are the latest trends, and strategies followed by leadings companies?
What is the market share of each Major Players specified in this report?
What are opportunities for Lab-on-a-chip and Microarrays(BIOCHIP) investors and market aspirants?
What are the major product types and which applications are known?
Which countries are analyzed in this report?
What is the market size, and demand for Lab-on-a-chip and Microarrays(BIOCHIP) on a global level?
What is the CAGR value of Lab-on-a-chip and Microarrays(BIOCHIP) Market?
About Us:
Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.
Contact Us:
http://www.acquiremarketresearch.com/
0 notes
Text
Biochips Market Size, Share Analysis, Key Companies, and Forecast To 2027
The biochips market has been growing significantly over the past few years. Biochips market size is expected to grow significantly over the forecast period. The market held a market value of USD 7,300 million in 2017 and is projected to grow at a CAGR of 16.6% over the forecast period.
Increasing technological advancements in biochips is a key driving force behind the growth of the market. Moreover, increasing the adoption of personalized medicine in cancer genomics applications are fostering the growth of the market. Furthermore, growing applications of biochips would help in boosting the growth in the market during the review period.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7063
Moreover, increasing mergers and acquisition, growing collaborations and partnerships, and product launches are some of the latest trends in the global biochips market. Furthermore, factors such as the increasing clinical trials and drug discovery activities, advancements such as lab-on-chip and splice variants, the wider application area of microarray, and government initiatives & support are expected to develop new market opportunities.
On the flip side, substantially high cost of the instruments and stringent regulatory guidelines are some of the significant factors inhibiting the growth of the global biochips market. Also, the lack of standardization in microarray data, and skilled professionals may restrain the growth of the market. Nevertheless, factors such as the need for early cancer detection, diagnosis, and large-scale DNA/gene chip initiatives are some of the predominant factors expected to support market growth over the assessment period.
Global Biochips Market - Segments
The report is segmented into four key market dynamics to widen the scope of understanding,
By Type : DNA Chips, Lab-on-a-Chip, Cell Arrays, Tissue Arrays, and Protein Chips, among others.
By Technology: Microarrays and Microfluidics.
By End-user: Biotechnology & Pharmaceutical Companies, Hospitals, and Diagnostics Centers, among others.
By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.
Global Biochips Market - Regional Analysis
North America dominates the global biochips market followed by Europe. High per-capita healthcare expenses and the presence of major market players and well-established healthcare sector are the major factors driving the biochips market in North America. Furthermore, increasing technological advancement, growing research & development activities, increasing cancer incidences, and increasing government support are fostering the regional market growth.
The biochips market in the European region holds hold the second-largest share in the global market. The presence of strong academic & research base and availability of funding for research in the European countries drives the regional market growth. Moreover, factors such as improving healthcare infrastructure, growing prevalence of chronic diseases, increasing government expenditure, growing drug discovery, and development activities are acting as a significant tailwind to the biochips market in Europe.
The Asia pacific biochips market is an emerging market, globally. Increasing government focus on biomedical and biotechnology sector and the growing number of target population in the region foster the regional market growth. The biochips market in the rapidly developing economies, China and India are emerging due to an improved lifestyle, growing awareness about biochips & their benefits, and increasing government support.
In India, top pharma companies are now partly foreign-owned and are already generating more than half of their sales outside the country. Besides, economic growth has increased healthcare expenses in India.
Global Biochips Market - Competitive Analysis
Characterized by the presence of many large and small players, the global biochips market appears to be highly competitive as well as fragmented. These well-established players incorporate strategic initiatives such as acquisition, collaboration, expansion, and product launch to gain a competitive advantage in this market. Players operating in the biochips market compete based on pricing, availability, brand, and variety.
Major Players:
Players leading the global biochips market include Fluidigm Corporation, Perkinelmer, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, Cepheid Inc., GE Healthcare, Illumina, Inc., Thermo Fisher Scientific, Inc, and Roche Diagnostics among others.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/biochips-market-7063
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Have a Look at Related Reports:
Pharmaceutical Analytical Testing Outsourcing Market - https://www.medgadget.com/2019/11/pharmaceutical-analytical-testing-outsourcing-market-driven-by-increasing-drug-development-activity-in-north-america-europe-mrfr-published-global-analysis-by-2023.html
Radiopharmaceutical Market - https://www.medgadget.com/2019/11/radiopharmaceutical-market-overview-and-manufacturing-cost-structure-global-size-share-business-strategy-investments-by-major-players-and-forecast-to-2023.html
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
1 note
·
View note
Text
Global and Regional Biochips Industry Status and Prospects Professional Market Research Report Standard Version 2021-2027
The global Biochips market was valued at 8689.25 Million USD in 2020 and will grow with a CAGR of 8.93% from 2020 to 2027, based on Our Researcher newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the same. Thus, they help in cost and time saving.North America accounted for the largest share of the biochips market in 2017. The large share of this regional segment can majorly be attributed to the rising geriatric population; increasing prevalence of lifestyle diseases, such as diabetes, asthma, and cardiac disorders; growing adoption of biochips; and a significant number of ongoing research activities and discoveries related to biochips in the North American region. In addition, major local companies have easy access to Biochips market, which makes it the largest and most significant market for suppliers. Asia-Pacific, on the other hand, is expected to grow at the highest CAGR over the next five years.
Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-regional-biochips-2021-2027-770
By Market Verdors:
Abbott
Agilent Technologies
Illumina
PerkinElmer
Thermo Fisher Scientific
BioChain
Bio-Rad Laboratories
Cepheid
EMD Millipore
Fluidigm
SuperBioChips Laboratories
US Biomax
Roche Diagnostics
By Types:
DNA Chip
Lab-on-a-Chip
Protein Chip
By Applications:
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-regional-biochips-2021-2027-770
Table of content
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Biochips Market Size Analysis from 2022 to 2027 1.5.1 Global Biochips Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Biochips Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Biochips Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Biochips Industry Impact Chapter 2 Global Biochips Competition by Types, Applications, and Top Regions and Countries 2.1 Global Biochips (Volume and Value) by Type 2.1.1 Global Biochips Consumption and Market Share by Type (2016-2021) 2.1.2 Global Biochips Revenue and Market Share by Type (2016-2021) 2.2 Global Biochips (Volume and Value) by Application 2.2.1 Global Biochips Consumption and Market Share by Application (2016-2021) 2.2.2 Global Biochips Revenue and Market Share by Application (201
CONTACT US: 276 5th Avenue, New York , NY 10001,United States International: (+1) 646 781 7170 / +91 8087042414 Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
1 note
·
View note
Text
Biochip Market Segmentation, Industry Analysis By Production, Consumption, Revenue And Growth Rate By 2028
The Global Biochip Market size was valued at USD 11.49 Billion in 2020 and is forecast to reach USD 29.90 Billion, at a CAGR of 11.7% through 2028, according to a new report by Reports and Data. The market growth is driven by increasing application of biochip in proteomics, genomics, and drug discovery, coupled with high investment in R&D.
Biochip technologies have a significant impact on genomic research. Various fields such as drug discovery, gene discovery, medical diagnostics, and toxicological research, are benefitting from the use of biochip technologies. Biochip technology is expensive, and its high cost is associated with the complexity of technology, various resources and extensive R&D that goes in for the product manufacturing. Several research institutes are focusing on enhancing the precision of the product while reducing costs and time. Rise in R&D investment, government funding and high potential in untapped markets is expected to offer lucrative growth opportunities for the biochip market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1375
The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers. The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors. It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships.
Key Companies in the market include:
bioMrieux S.A., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, HORIBA Ltd., Illumina, Inc., PerkinElmer, Inc., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., and QIAGEN N.V., among others.
Regional segmentation comprises of a current and forecast estimation of the market in the key geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region.
Market segment analysis:
Product Outlook (Revenue, USD Billion; 2018-2028)
DNA Chip
Lab-on-chip
Protein Chip
Others
Technology Outlook (Revenue, USD Billion; 2018-2028)
Microfluidics
Microarray
Substrate Materials Outlook (Revenue, USD Billion; 2018-2028)
Glass
Polymers
Silicon
Others
Applications Outlook (Revenue, USD Billion; 2018-2028)
Genomics
Proteomics
Drug Discovery and Developments
In Vitro Diagnostics
Disease Diagnostics
Agriculture
End Users Outlook (Revenue, USD Billion; 2018-2028)
Pharmaceutical and Biotechnology Company
Academic and research institute
Hospitals and diagnostic centers
Other end users
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1375
On the basis of regional analysis, the market is segmented into key geographical regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. According to the analysis, North America is expected to dominate the market with the highest market share. Asia-Pacific is anticipated to show a significant growth rate owing to rising development and population demands.
To know more about the report @ https://www.reportsanddata.com/report-detail/biochip-market
Key Features of the Global Biochip Market Report:
Comprehensive analysis of the key players operating in the market along with their SWOT analysis, their business profiles, business overview, market share, global position, and market value
Identification and analysis of significant trends and factors driving revenue growth of the market
Analysis of the competitive landscape along with strategic mergers, expansions, agreements, partnerships, joint ventures, acquisitions, and product launches
Assessment of each market segment along with their growth trends and market revenue contribution
Study of the key regions to pinpoint growth potential and study opportunities, threats, limitations, and risks
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1375
Thank you for reading our report. Customization of this report is available according to the client’s needs. Please get in touch with us to know more about the customization feature and our team will ensure the report is tailored as per your requirements.
Browse More Details:
Hernia Mesh Market Share
Spun Bond Non-Woven Market Size
1 note
·
View note
Text
World Biochips Market Analysis, Size, Share, Growth, Sales Statistics Key Players 2027
Market Insights:
Market Research Future (MRFR) provides an in-depth analysis of regional data with Growth Potential, Opportunities, Drivers, Industry-Specific Challenges for Worldwide Biochips Market.
Global Biochips Market held a market value of USD 7,300 million in 2017, according to the MRFR. The market is expected to exhibit a strong 16.6% CAGR over the forecast period from 2018 to 2023, according to the report.
Biochips are intended to function in biological environment, preferably inside living organism. The factors such as increasing technological advancements in biochips is the major driving factor for the market. Moreover, increasing adoption of personalized medicine, as personalised medicine has many applications in cancer genomics. Furthermore, growing applications of biochips will boost the market growth during forecast period. For instance, biochips can perform thousands of biological reactions operations in few seconds.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7063
However, high cost of the instruments and stringent regulatory guidelines may restrain the growth of the Biochips Market share
According to national Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people may die from the disease.
Competitive Landscape:
Perkinelmer, Inc.,
Fluidigm Corporation,
Agilent Technologies, Inc.,
Abbott Laboratories,
Bio-Rad Laboratories Inc.,
Cepheid Inc.,
Illumina, Inc.,
GE Healthcare,
Thermo Fisher Scientific, Inc,
Roche Diagnostics
Segmentation:
The Global Biochips Market has been segmented into type, technology, and end user.
By type, the market has been segmented into DNA chips, lab-on-a-chip, protein chips, cell arrays, and tissue arrays. DNA chips is further segmented into gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, drug discovery, agricultural biotechnology, and others. Lab-on-a-chip is further segmented into clinical diagnostics, genomics, IVD (In-Vitro Diagnostic) & POC (Point of care), Proteomics, Drug Discovery, and others. Protein chips is further segmented into proteomics, expression profiling, diagnostics, high-throughput screening, drug discovery, others.
Based on technology, the market has been segmented into microarrays and microfluidics.
The biochips market, by end user, has been segmented into biotechnology and pharmaceutical companies, hospitals and diagnostics centers, academic & research institutes, and others.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global biochips market owing to the high domestic income, and presence of major market players. Moreover, increasing patient population in US. According to American Cancer Society, the overall estimate of 1,735,350 cases for 2018 equals more than 4,700 new cancer diagnoses each day.
Europe is expected to hold the second largest position in the global biochips market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).
The biochips market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of target population in the region.
The Middle East & Africa has the lowest share of the global biochips market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Browse Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/biochips-market-7063 About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
0 notes
Text
Biochip Market to Witness a 12.52% CAGR By 2026 | TechSci Research
Growing prevalence of chronic as well as infectious disease and increasing demand for personalized medicine are some major factors propelling the growth of the global biochip market.
According to TechSci Research report, “Global Biochip Market By Technology (Microarray v/s Microfluidics), By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others), By Company, By Region, Forecast & Opportunities, 2026”, the biochip market was valued at USD11694.24 million in 2020 and is expected to reach USD23890.58 million by registering a CAGR of 12.52%. The increasing prevalence of various chronic diseases like cancer, immunological disorders and other infectious diseases, especially among the geriatric population is acting as a major growth factor for the global biochip market. Moreover, the rising demand for targeted therapies and personalized medicines, extensive R&D activities and supportive government policies are some other key factors supporting the global biochip market growth. Furthermore, ongoing technological innovations and new product launches by major players operating in the market are expected to create lucrative growth opportunities for the market over the next five years. Additionally, biochips are also finding applications in the field of genomics, genotyping and proteomics. This in turn is likely to positively influence the market growth through 2026. Apart from that, various economies are increasing spending on clinical research which is further augmenting the growth of the global biochip market. However, the high cost of biochips and lack of awareness especially in developing and underdeveloped countries can hamper the market growth.
Browse 132 Figures spread through 110 Pages and an in-depth TOC on "Global Biochip Market"
https://www.techsciresearch.com/report/global-biochip-market/1259.html
The global biochip market is segmented based on type, technology, application, end user and region. Based on end user, the market can be fragmented into biotechnology & pharmaceutical companies, hospitals & diagnostics centers, academic & research institutes, and others. The hospitals & diagnostic centers segment dominated the market in 2020 by holding 40.53% of the market share and is expected to maintain its leading position in the market on account of the extensive use of biochips by them. This can be ascribed to the associated advantages of biochips such as affordability, time saving and ability to deliver high throughput without requiring instruments. In terms of application, the market is fragmented into drug discovery & development, disease diagnostics, genomics, proteomics, others. Out of which, the drug discovery & development application segment held the largest market share in 2020 on account of the growing development of targeted and personalized medicines for treating cancer. Also, the disease diagnostics segment is projected to witness the highest growth in the forthcoming years due to the rising demand for the detection and diagnosis of genetic disorders across the globe. Based on type, the market can be categorized into DNA Chips, Lab-On-a-Chips and Protein Chips. Out of which, the DNA chips segment dominated the market in 2020 on account of its widespread adoption and use of DNA chip products. Moreover, increased spending on research related to genomics and next-generation sequencing is further contributing to the growing demand for DNA biochips.
Major players operating in the global biochip market are Abbott Laboratories Ltd., Agilent Technologies, Inc., PerkinElmer Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, bioMérieux SA, Horiba, Ltd., Qiagen N.V., Randox Laboratories Ltd., OriGene Technologies, Inc., Hologic, Inc., among others. Companies are investing in developing advanced technologies and launching new services in order to enhance their product portfolio and are also undergoing inorganic growth strategies such as mergers & acquisitions, strategic partnerships, collaborations and joint ventures.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=1259
Customers can also request for 10% free customization on this report.
“Regionally, North America is expected to dominate the global biochip market through 2026 on account of growing prevalence of various sedentary lifestyle associated diseases in the countries like United States and Canada. However, the Asia Pacific region is expected to register the fastest CAGR during the forecast period owing to the growth in life science industry and improving healthcare facilities in the region. Additionally, major players operating in the market are expanding their business in the region especially in countries like India and China, positively influencing the growth of the market.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Biochip Market By Technology (Microarray v/s Microfluidics), By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others), By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of biochip market and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in the global biochip market.
Browse Related Reports:
United States Infectious Disease Biomarker Testing Market By Product (Assays, Platforms), By Application (Respiratory Infection, Sexually Transmitted Infection, Bloodstream and Hospital-Acquired Infection, Urinary Tract Infection, Gastro-Intestinal Infection, Central Nervous System Infection, Others), By Technology (PCR, NGS, ELISA or EIA, IHC, ISH, Others), By Pathogen (Virus, Bacteria), By End User (Hospitals and Clinics, Diagnostic Centers, Research Laboratories, Others), By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/united-states-infectious-disease-biomarker-testing-market/5120.html
Global Dermal Fillers Market By Type (Biodegradable, Non-biodegradable), By Material Type (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, Polymethyl-methacrylate Microspheres [PMMA], Collagen, Others), By Application (Wrinkle Correction Treatment, Facial Line Correction, Face Lift, Lip Enhancement, Scar Treatment, Others), By End Use (Dermatology Clinics, Hospitals, Beauty Clinics, Others), By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/dermal-fillers-market/5109.html
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
#TechSci#Market Research Reports#Global Biochip Market#Biochip Market#Biochip Market Size#Biochip Market Share#Biochip Market Trend#Healthcare#Biochip Market Forecast
0 notes
Text
Biochip Market to Witness a 12.52% CAGR By 2026 | TechSci Research
Growing prevalence of chronic as well as infectious disease and increasing demand for personalized medicine are some major factors propelling the growth of the global biochip market.
According to TechSci Research report, “Global Biochip Market By Technology (Microarray v/s Microfluidics), By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others), By Company, By Region, Forecast & Opportunities, 2026”, the biochip market was valued at USD11694.24 million in 2020 and is expected to reach USD23890.58 million by registering a CAGR of 12.52%. The increasing prevalence of various chronic diseases like cancer, immunological disorders and other infectious diseases, especially among the geriatric population is acting as a major growth factor for the global biochip market. Moreover, the rising demand for targeted therapies and personalized medicines, extensive R&D activities and supportive government policies are some other key factors supporting the global biochip market growth. Furthermore, ongoing technological innovations and new product launches by major players operating in the market are expected to create lucrative growth opportunities for the market over the next five years. Additionally, biochips are also finding applications in the field of genomics, genotyping and proteomics. This in turn is likely to positively influence the market growth through 2026. Apart from that, various economies are increasing spending on clinical research which is further augmenting the growth of the global biochip market. However, the high cost of biochips and lack of awareness especially in developing and underdeveloped countries can hamper the market growth.
Browse 132 Figures spread through 110 Pages and an in-depth TOC on "Global Biochip Market"
https://www.techsciresearch.com/report/global-biochip-market/1259.html
The global biochip market is segmented based on type, technology, application, end user and region. Based on end user, the market can be fragmented into biotechnology & pharmaceutical companies, hospitals & diagnostics centers, academic & research institutes, and others. The hospitals & diagnostic centers segment dominated the market in 2020 by holding 40.53% of the market share and is expected to maintain its leading position in the market on account of the extensive use of biochips by them. This can be ascribed to the associated advantages of biochips such as affordability, time saving and ability to deliver high throughput without requiring instruments. In terms of application, the market is fragmented into drug discovery & development, disease diagnostics, genomics, proteomics, others. Out of which, the drug discovery & development application segment held the largest market share in 2020 on account of the growing development of targeted and personalized medicines for treating cancer. Also, the disease diagnostics segment is projected to witness the highest growth in the forthcoming years due to the rising demand for the detection and diagnosis of genetic disorders across the globe. Based on type, the market can be categorized into DNA Chips, Lab-On-a-Chips and Protein Chips. Out of which, the DNA chips segment dominated the market in 2020 on account of its widespread adoption and use of DNA chip products. Moreover, increased spending on research related to genomics and next-generation sequencing is further contributing to the growing demand for DNA biochips.
Major players operating in the global biochip market are Abbott Laboratories Ltd., Agilent Technologies, Inc., PerkinElmer Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, bioMérieux SA, Horiba, Ltd., Qiagen N.V., Randox Laboratories Ltd., OriGene Technologies, Inc., Hologic, Inc., among others. Companies are investing in developing advanced technologies and launching new services in order to enhance their product portfolio and are also undergoing inorganic growth strategies such as mergers & acquisitions, strategic partnerships, collaborations and joint ventures.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=1259
Customers can also request for 10% free customization on this report.
“Regionally, North America is expected to dominate the global biochip market through 2026 on account of growing prevalence of various sedentary lifestyle associated diseases in the countries like United States and Canada. However, the Asia Pacific region is expected to register the fastest CAGR during the forecast period owing to the growth in life science industry and improving healthcare facilities in the region. Additionally, major players operating in the market are expanding their business in the region especially in countries like India and China, positively influencing the growth of the market.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Biochip Market By Technology (Microarray v/s Microfluidics), By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others), By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of biochip market and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in the global biochip market.
Browse Related Reports:
United States Infectious Disease Biomarker Testing Market By Product (Assays, Platforms), By Application (Respiratory Infection, Sexually Transmitted Infection, Bloodstream and Hospital-Acquired Infection, Urinary Tract Infection, Gastro-Intestinal Infection, Central Nervous System Infection, Others), By Technology (PCR, NGS, ELISA or EIA, IHC, ISH, Others), By Pathogen (Virus, Bacteria), By End User (Hospitals and Clinics, Diagnostic Centers, Research Laboratories, Others), By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/united-states-infectious-disease-biomarker-testing-market/5120.html
Global Dermal Fillers Market By Type (Biodegradable, Non-biodegradable), By Material Type (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, Polymethyl-methacrylate Microspheres [PMMA], Collagen, Others), By Application (Wrinkle Correction Treatment, Facial Line Correction, Face Lift, Lip Enhancement, Scar Treatment, Others), By End Use (Dermatology Clinics, Hospitals, Beauty Clinics, Others), By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/dermal-fillers-market/5109.html
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
#TechSci#Market Research Reports#Global Biochip Market#Biochip Market#Biochip Market Size#Biochip Market Share#Biochip Market Trend#Biochip Market Forecast#Healthcare
0 notes
Text
Global Biochips Market Size, Growth Analysis Report, Forecast to 2021-2027
The global biochips market is growing at a CAGR of nearly 13.5% during the forecast period (2021-2027). The market growth is mainly attributed to the rising technological innovations in biochips. The rising innovations in biochips have been gradually rising over the years to obtain high throughput in less time. Therefore, the new product launches of biochips have witnessed that is expected to offer researchers several choices to use biochips as per their needs. Additionally, advances in biochips support to drive next-generation DNA sequencing technologies. It is a strong combination that can solve unique and important biological problems, including rare-cell, single-cell, or rare-molecule analysis, which is not possible by using only next-generation sequencing (NGS).
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/biochips-market
Additionally, the funding opportunity for biochips research is driving innovations in the field of biochips. For instance, in February 2021, Le Zhun Zhi Xin (Legendic), a developer of biological chips and testing platform, declared the closing of a Pre-A round of financing worth $5.4 million, led by Sinocare. The raised funds will be utilized for the development of a manufacturing facility and the development of new products. Additionally, these funds will be used to promote the marketing of the company's biochips, procalcitonin detection kits, and instruments with the use of chemiluminescence.
A Full Report of Global Biochips Market is Available at: https://www.omrglobal.com/industry-reports/biochips-market
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Biochips Market Report Segment
By Type
DNA Chips
Lab-on-a-Chip
Protein Chips
Others
By Fabrication Technology
Microarrays
Microfluidics
By End-User
Hospitals and Diagnostic Centers
Academic and Research Institutes
Biotechnology and Pharmaceutical Companies
Global Biochips Market Report Segment by Region
North America
US
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/biochips-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected] Contact no: +91 780-304-0404
0 notes
Text
Separation Systems for Commercial Biotechnology Market Size Report Till 2024 Focusing on Key Players : WATERS & Sartorius
Global Separation Systems for Commercial Biotechnology Market size is expected to reach USD 39.47 billion by 2025. The separation systems in biotechnology are also termed as “bioseparation systems”. Bioseparation systems are used for the purification and separation of biological products such as biopharmaceuticals, biochemicals and diagnostic reagents depending upon electrostatic charge, density, diffusivity, shape, polarity, solubility, and volatility characteristics. The equipment’s used for the separation of biological material from complex mixture or solution include chromatography, membrane/ filters, and centrifuges. The separation systems for commercial biotechnology industry is expected to grow at the highest CAGR over the forecast period as the scope, product types, and its applications are increasing across the world.
The factors that play an important role in the growth of separation systems for commercial biotechnology market include increasing demand for novel drug molecules & cell-based therapies, booming biopharmaceutical & biotech firms, technological advancements in biotechnology sector, and stringent government rules & regulations. However, high cost of bioseparation equipment’s and strict regulations regarding bioseparation systems are negatively affecting the growth of the market. The separation systems for commercial biotechnology industry is categorized based on method, application and geography.
Methods that could be explored in separation systems for commercial biotechnology market include conventional methods and modern methods. The conventional methods are classified into flow cytometry, chromatography, membrane filtration, centrifugation, electrophoresis, and others while the “modern methods” is segmented into lab-on-a-chip, microarray, biochip, magnetic separation and others. Conventional methods are expected to hold the largest market share in the forthcoming years. High investment by industrial key players for innovation of enhanced techniques such as membrane filtration and flow cytometry systems are factors driving the growth of conventional methods in the future period. However, modern methods are anticipated to grow at fastest pace in the years to come due to rising adoption of enhanced technology and increasing ongoing inventions in the biotechnology field.
Applications such as pharmaceutical, agriculture, food & cosmetics, energy, life sciences research and others could be explored in separation systems for commercial biotechnology industry in the coming years. Pharmaceutical is expected to be the largest application due to rising demand for biotherapies and ongoing inventions in the field of novel drug molecules.
Access Sample Report of this report @ https://www.millioninsights.com/industry-reports/separation-systems-for-commercial-biotechnology-market/request-sample
North America is expected to be the top market for separation systems for commercial biotechnology in the future period. The presence of key manufacturers, growing technological advancements, and continuous R&D are anticipated to drive the market in this region in upcoming period. The U.S. represents the largest market for bioseparation systems in North America, followed by Canada. Further Europe and the Asia Pacific follow the market.
On the other hand, the Asia Pacific’s market is projected to hold higher share in the separation systems for commercial biotechnology market in forecast period. As increasing R&D expenditure and government initiative for the development of separation system in emerging countries such as India & China. Also, shortage of vaccines across the world, high demand for therapeutics, and ongoing research in the biotechnology field are expected to boost the market growth in this region.
The key players operating in the separation systems for commercial biotechnology industry are Shimadzu Corporation, MiltenyiBiotec, PerkinElmerInc., GE Healthcare, Agilent Technologies, Bio-Rad LaboratoriesInc., Thermo Fisher Scientific, Merck & Co.Inc., bioMérieux SA, Hitachi Koki Co.Ltd., WATERS, Sartorius, QIAGEN, Danaher and BD. These market players strongly invest in the expansion of their business and development of new biotechnologies system to maintain a top position in the market. Also, these players concentrating on new joint ventures, collaborations, agreements, and strategies to improve their production facilities and gain a larger share in the market.
Market Segment:
Method Outlook (Revenue, USD Million; 2014 - 2025) • Modern methods • Microarray • Lab-on-a-chip • Biochip • Magnetic separation • Conventional methods • Chromatography • Flow cytometry • Membrane filtration • Electrophoresis • Centrifugation
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/separation-systems-for-commercial-biotechnology-market
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email:[email protected]
0 notes
Text
Separation Systems for Commercial Biotechnology Market Top Players Financial Performance and Strategic Initiatives
The global Separation Systems for Commercial Biotechnology Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.
Market Overview:
Global Separation Systems for Commercial Biotechnology Market size is expected to reach USD 39.47 billion by 2025. The separation systems in biotechnology are also termed as “bioseparation systems”. Bioseparation systems are used for the purification and separation of biological products such as biopharmaceuticals, biochemicals and diagnostic reagents depending upon electrostatic charge, density, diffusivity, shape, polarity, solubility, and volatility characteristics.
Key Players:
Perkin Elmer, Inc.
Sartorius AG
Thermo Fisher Scientific, Inc.
Merck KGaA
Danaher
Becton, Dickinson and Company (BD)
Shimadzu Corporation
bioMérieux SA
Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/separation-systems-for-commercial-biotechnology-market/request-sample
Growth Drivers:
The separation systems for commercial biotechnology industry are expected to grow at the highest CAGR over the forecast period as the scope, product types, and its applications are increasing across the world. The factors that play an important role in the growth of separation systems for commercial biotechnology market include increasing demand for novel drug molecules & cell-based therapies, booming biopharmaceutical & biotech firms, technological advancements in biotechnology sector, and stringent government rules & regulations. However, high cost of bioseparation equipment’s and strict regulations regarding bioseparation systems are negatively affecting the growth of the market. The separation systems for commercial biotechnology industry are categorized based on method, application and geography.
Method Outlook:
Modern methods
Conventional methods
Microarray
Lab-on-a-chip
Biochip
Magnetic separation
Chromatography
Flow cytometry
Membrane filtration
Electrophoresis
Centrifugation
Application Outlook:
Pharmaceutical
Food & Cosmetics
Agriculture
Vaccines
Proteins
Hormones/Insulin
Enzymes
Human Blood Plasma Fractionation
Mammalian Cell Cultures
Regional Outlook:
North America is expected to be the top market for separation systems for commercial biotechnology in the future period. The presence of key manufacturers, growing technological advancements, and continuous R&D are anticipated to drive the market in this region in upcoming period. The U.S. represents the largest market for bioseparation systems in North America, followed by Canada. Further Europe and the Asia Pacific follow the market.
On the other hand, the Asia Pacific’s market is projected to hold higher share in the separation systems for commercial biotechnology market in forecast period. As increasing R&D expenditure and government initiative for the development of separation system in emerging countries such as India & China. Also, shortage of vaccines across the world, high demand for therapeutics, and ongoing research in the biotechnology field are expected to boost the market growth in this region.
Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/
0 notes
Text
Lab-on-a-chip and Microarrays(BIOCHIP) Market 2020 Analysis & Recent Developments, Share to 2025
The research report on Lab-on-a-chip and Microarrays(BIOCHIP) market as well as industry is an in-depth study that provides detailed information of leading players, qualitative analysis and quantitative analysis, types & end-users; historical figures, region analysis, market technology landscape & restraints, strategic planning, and a precise section for the effect of Covid-19 on the industry. Our research analysts intensively determine the significant outlook of the global Lab-on-a-chip and Microarrays(BIOCHIP) market study with regard to primary research & secondary research and they have represented it in the form of figures, pie charts, tables & other pictorial representations for better understanding.
To Know More Details About This Report, Get Sample @ http://www.acquiremarketresearch.com/sample-request/348565
The report on Lab-on-a-chip and Microarrays(BIOCHIP) market claims this industry to emerge as one of the most lucrative spaces in the ensuing years, exhibiting a modest growth rate over the forecast period. Enumerating a highly exhaustive outline of Lab-on-a-chip and Microarrays(BIOCHIP) Market size, this report is also inclusive of the total valuation that the Lab-on-a-chip and Microarrays(BIOCHIP) industry presently holds, a brief segmentation of this market and Lab-on-a-chip and Microarrays(BIOCHIP) market growth opportunities of this industry in addition to its geographical expanse.
Major Key Players Covered In This Report:
Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Beckman Coulter, Cepheid, Fluidigm, GE Healthcare, Roche Holding, Illumina, Biomerieux, Thermo Fisher Scientific, PerkinElmer
Lab-on-a-chip and Microarrays(BIOCHIP) Market Analysis by 2020
This research report based on ‘Lab-on-a-chip and Microarrays(BIOCHIP) market’ and available with Acquire Market Research includes latest and upcoming market trends in addition to the global spectrum of the ‘Lab-on-a-chip and Microarrays(BIOCHIP) market’ that includes numerous regions. Moreover, the research also expands on intricate details pertaining to contributions by key Manufacturers, import & export, demand and supply analysis as well as industry size, share growth of the Lab-on-a-chip and Microarrays(BIOCHIP) industry.
The specified segments and sub-sections of the market are explained below:
By Product Type:
DNA Microarrays, Microfluidics
By Application/End-user:
Genomics, Proteomics, Cell Assays, Clinical Diagnostics, Drug Discovery, Others
By country/region:
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Check Discount @ http://www.acquiremarketresearch.com/discount-request/348565
Frequently Asked Questions About This Market Research Report:
What are the latest trends, and strategies followed by leadings companies?
What is the market share of each Major Players specified in this report?
What are opportunities for Lab-on-a-chip and Microarrays(BIOCHIP) investors and market aspirants?
What are the major product types and which applications are known?
Which countries are analyzed in this report?
What is the market size, and demand for Lab-on-a-chip and Microarrays(BIOCHIP) on a global level?
What is the CAGR value of Lab-on-a-chip and Microarrays(BIOCHIP) Market?
About Us:
Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.
Contact Us:
http://www.acquiremarketresearch.com/
0 notes
Text
According to New Market Report Global Biochips Market is to Witness Highest Growth in near future Forecast 2018-2025
Biochip is a miniaturized medical device, which performs several biochemical reactions. This device is a collection of microarrays or micro-test strips that are arranged on the surface of chip, and are meant to perform multiple tests simultaneously. Biochip is extremely small in size ranging from 2 inches to 12 inches. These chips can perform various biotechnology applications such as decoding genes and searching for contaminations in the sample in a few seconds.
Request for Sample @ https://www.kdmarketinsights.com/sample/3467
The global biochips market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025 at a CAGR of 11.2% from 2018 to 2025. Factors such as rise in prevalence of various life-threatening diseases increases the demand for disease diagnostics, which in turn drives the growth of the global biochips market. Moreover, rise in adoption of personalized medicines and presence of large geriatric population boost the market growth. However, lack of knowledge related to biochips and their high cost of hamper the market growth. Conversely, huge untapped potential in the emerging countries, such as China and India, and rise in R&D investment as well as government funding are expected to offer lucrative opportunities to the market players.
The global biochips market is segmented based on product, application, end user, and region. Depending on product, the market is divided into DNA chip, protein chip, lab-on-a-chip, and others. By application, it is categorized into drug discovery & development, disease diagnostics, genomics, proteomics, agriculture, and other applications. On the basis of end user, it is classified into biotechnology & pharmaceutical companies, hospitals & diagnostics centers, academic & research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Biochips Market :
- The study provides an in-depth analysis of the global biochips market along with current trends and future estimations from 2018 to 2025 to elucidate the imminent investment pockets.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
- Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Biochips Key market segments :
By Product
- DNA Chip
- Protein Chip
- Lab-on-a-chip
- Others
By Application
- Drug Discovery & Development
- Disease Diagnostics
- Genomics
- Proteomics
- Agriculture
- Others
By End User
- Biotechnology & Pharmaceutical Companies
- Hospitals & Diagnostics Centers
- Academic & Research Institutes
- Others
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- Fluidigm Corporation
- HORIBA, Ltd.
- Illumina, Inc.
- PerkinElmer, Inc.
- QIAGEN N.V.
- Randox Laboratories Ltd.
- Thermo Fisher Scientific Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
- Micronit Microfluidics BV
- OriGene Technologies, Inc.
- ANALIS sa/nv
- AMS Alliance
- Dynamic Biosensors GmbH
Read More Full Report@ https://www.kdmarketinsights.com/product/biochips-market-amr
Table of Content
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of key players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017 (%)
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the incidence life threatening disorders
3.4.1.2. Rise in geriatric population
3.4.1.3. High demand of personalized medicines
3.4.1.4. Large number of biochips applications
3.4.2. Restraints
3.4.2.1. High cost of biochips
3.4.2.2. Lack of awareness in developing countries
3.4.3. Opportunity
3.4.3.1. Untapped market opportunities in the developing regions
3.4.4. Impact analyses
CHAPTER 4: BIOCHIPS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast, by product
4.2. DNA chip
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Protein chip
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Lab-on-chip
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Others
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: BIOCHIPS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by revenue
5.2. Drug discovery and development
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Disease diagnostics
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Genomics
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Proteomics
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Agriculture
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
5.7. Other applications
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country
Continue…
Check for Discount @ https://www.kdmarketinsights.com/discount/3467
About KD Market Insights
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.
Contact Us
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: [email protected]
Website:
www.kdmarketinsights.com
#Biochips Market#Biochips Market Size#Biochips Market Share#Biochips Market Growth#Biochips Market Trends
0 notes
Text
Latest Opportunities In Global Biochips Market With Economic Growth And Five Forces Analysis
[170 Pages Report] The overall biochips market size is estimated to grow at a CAGR of 18.4% from 2015 to 2020 to reach $17.75 billion by 2020.
The Report"Biochips Market Size & Share by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), Fabrication Technology (Microarrays, Microfluidics), End user (Academics Institutes, Diagnostics Centers) - Global Forecast to 2020".
The development of targeted and personalized medicines for the treatment of cancer and technological advancements in biochips are also supporting the growth of biochip products. The objective of Market report is to define, describe, and forecast the global market of biochips on the basis of type, applications, end user, and region. It provides detailed information regarding the major factors influencing the growth of overall market. Drivers, restraints, opportunities, challenges, and trends in the market have also been taken into consideration while preparing this report. This report also tracks and analyzes competitive developments of the key players in market in terms of market developments, product portfolios, and key financials.
Download a free pdf broucher @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of various other dependent submarkets. The fabrication technology markets for all segments were determined through secondary research and were added up to obtain the global market value. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources.
This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources we referred are U.S. Food and Drug Administration, Journal of Biochips & Tissue Chips, American Medical Association (AMA), National Cancer Institute, Journal of Molecular Diagnostic and The World Bank.
Key Market Players
Key players in the biochips market include Abbott Laboratories (US), Agilent Technologies, Inc. (US), PerkinElmer Inc. (US), Fluidigm Corporation (US), Illumina, Inc. (US), GE Healthcare (US), Bio-Rad Laboratories Inc. (US), Cepheid Inc. (US), Thermo Fisher Scientific, Inc. (US), and F. Hoffmann-La Roche AG (Switzerland).
Get Sample Report with all Graphs & Charts related to it @: https://www.marketsandmarkets.com/requestsampleNew.asp?id=54
#Biochips Market#Global Biochips Market#Biochips Market 2019#Biochips Market latest report#Biochips Market latest trends#Biochips Market future#Biochips Market Size#Biochips Market share#Biochips Market trends#Biochips Market growth#Biochips Market SWOT Analysis#Biochips Market Top Manufacturers#Biochips US Market#Biochips United States Market#Biochips Asia Pacific Market#Biochips Asia Market#Biochips Europe Market
0 notes
Text
Biochip Market Overview, Merger and Acquisitions , Drivers, Restraints and Industry Forecast By 2027
Reports and Data has recently published a new research report on Global Biochip Market that covers current development scenario and emerging trends of the market. The research report provides a comprehensive assessment of the market size, market share, revenue growth, and provides a futuristic perspective about the market trends, growth factors, facts, and industry validated market data. The report applies advanced statistical tools such as Porter’s Five Forces analysis and SWOT analysis to shed light on the competitive landscape of the global Biochip market. The report covers all the critical and essential information relating to the global Biochip market which helps the readers and clients gain a thorough understanding of the market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1375
The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers. The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors. It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships.
Key Companies in the market include:
bioMrieux S.A., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, HORIBA Ltd., Illumina, Inc., PerkinElmer, Inc., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., and QIAGEN N.V., among others.
Regional segmentation comprises of a current and forecast estimation of the market in the key geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region.
Market segment analysis:
Product Outlook (Revenue, USD Billion; 2017-2027)
DNA Chip
Lab-on-chip
Protein Chip
Others
Technology Outlook (Revenue, USD Billion; 2017-2027)
Microfluidics
Microarray
Substrate Material Outlook (Revenue, USD Billion; 2017-2027)
Glass
Polymers
Silicon
Others
Application Outlook (Revenue, USD Billion; 2017-2027)
Genomics
Proteomics
Drug Discovery and Developments
In Vitro Diagnostics
Disease Diagnostics
Agriculture
End-User Outlook (Revenue, USD Billion; 2017-2027)
Pharmaceutical and Biotechnology Company
Academic and research institute
Hospitals and diagnostic centers
Others
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1375
Regional analysis further covers a country-wise analysis to offer insights into key trends and demands in each major country that might affect the growth of the market in the region.
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
U.S.
Canada
Mexico
Germany
U.K.
Italy
France
BENELUX
Rest of Europe
China
India
Japan
South Korea
Rest of APAC
Brazil
Rest of LATAM
Saudi Arabia
A.E.
South Africa
Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/biochip-market
Key Features of the Global Biochip Market Report:
Comprehensive analysis of the key players operating in the market along with their SWOT analysis, their business profiles, business overview, market share, global position, and market value
Identification and analysis of significant trends and factors driving revenue growth of the market
Analysis of the competitive landscape along with strategic mergers, expansions, agreements, partnerships, joint ventures, acquisitions, and product launches
Assessment of each market segment along with their growth trends and market revenue contribution
Study of the key regions to pinpoint growth potential and study opportunities, threats, limitations, and risks
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1375
Thank you for reading our report. Customization of this report is available according to the client’s needs. Please get in touch with us to know more about the customization feature and our team will ensure the report is tailored as per your requirements.
1 note
·
View note
Text
Biochips Market Analysis, Size, Share, Growth and Trends by Forecast to 2023
Biochips Market Analysis
The biochips market has been growing significantly over the past few years. According to Market Research Future (MRFR), the global biochips market had valued at USD 7,300 MN, in 2017 and is estimated to grow exponentially over the next six years. In its recently published research report, MRFR also asserts that the market would register a CAGR of 16.6% throughout the forecast period (2018–2023).
Increasing technological advancements in biochips is a key driving force behind the growth of the market. Moreover, increasing the adoption of personalized medicine in cancer genomics applications are fostering the growth of the market. Furthermore, growing applications of biochips would help in boosting the growth in the market during the review period.
Moreover, increasing mergers and acquisition, growing collaborations and partnerships, and product launches are some of the latest trends in the global biochips market. Furthermore, factors such as the increasing clinical trials and drug discovery activities, advancements such as lab-on-chip and splice variants, the wider application area of microarray, and government initiatives & support are expected to develop new market opportunities.
On the flip side, substantially high cost of the instruments and stringent regulatory guidelines are some of the significant factors inhibiting the growth of the global biochips market. Also, the lack of standardization in microarray data, and skilled professionals may restrain the growth of the market. Nevertheless, factors such as the need for early cancer detection, diagnosis, and large-scale DNA/gene chip initiatives are some of the predominant factors expected to support market growth over the assessment period.
Avail Free Sample @ https://www.marketresearchfuture.com/sample_request/7063
Global Biochips Market - Segments
The report is segmented into four key market dynamics to widen the scope of understanding,
By Type: DNA Chips, Lab-on-a-Chip, Cell Arrays, Tissue Arrays, and Protein Chips, among others.
By Technology: Microarrays and Microfluidics.
By End-user: Biotechnology & Pharmaceutical Companies, Hospitals, and Diagnostics Centers, among others.
By Regions : Asia Pacific, North America, Europe, and the Rest-of-the-World.
Global Biochips Market - Regional Analysis
North America dominates the global biochips market followed by Europe. High per-capita healthcare expenses and the presence of major market players and well-established healthcare sector are the major factors driving the biochips market in North America. Furthermore, increasing technological advancement, growing research & development activities, increasing cancer incidences, and increasing government support are fostering the regional market growth.
The biochips market in the European region holds hold the second-largest share in the global market. The presence of strong academic & research base and availability of funding for research in the European countries drives the regional market growth. Moreover, factors such as improving healthcare infrastructure, growing prevalence of chronic diseases, increasing government expenditure, growing drug discovery, and development activities are acting as a significant tailwind to the biochips market in Europe.
The Asia pacific biochips market is an emerging market, globally. Increasing government focus on biomedical and biotechnology sector and the growing number of target population in the region foster the regional market growth. The biochips market in the rapidly developing economies, China and India are emerging due to an improved lifestyle, growing awareness about biochips & their benefits, and increasing government support.
In India, top pharma companies are now partly foreign-owned and are already generating more than half of their sales outside the country. Besides, economic growth has increased healthcare expenses in India.
Global Biochips Market - Competitive Analysis
Characterized by the presence of many large and small players, the global biochips market appears to be highly competitive as well as fragmented. These well-established players incorporate strategic initiatives such as acquisition, collaboration, expansion, and product launch to gain a competitive advantage in this market. Players operating in the biochips market compete based on pricing, availability, brand, and variety.
Obtain Premium Research Report Details @ https://www.marketresearchfuture.com/reports/biochips-market-7063
Biochips Market Major Players:
Players leading the global biochips market include Fluidigm Corporation, Perkinelmer, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, Cepheid Inc., GE Healthcare, Illumina, Inc., Thermo Fisher Scientific, Inc, and Roche Diagnostics among others.
0 notes
Text
Wearable Patches Market to grow at Double Digit CAGR during the Forecast Period | TechSci Research
Technology advancement of wearable patches and increase in chronic diseases is expected to drive the global wearable patches market.
According to TechSci Research report, “Global Wearable Patches Market, By Technology (Connected v/s Regular), By Application (Monitoring, Drug Delivery, Diagnostics, Others), By End User (Healthcare v/s Fitness & Sports), By Company, By Region (North America, South America, Asia Pacific, Middle East & Africa, Europe), Forecast & Opportunities, 2026”, the market for the global wearable patches market is expected to witness significant growth during the forecast period. Rising obesity observed around the globe and unhealthy living conditions is leading to generation of chronic diseases and other serious conditions for instance diabetes and atrial fibrillation. Wearable patches consist of sensors and actuators and are used for monitoring and early diagnosis of chronic diseases. Patches are used for monitoring, diagnosis and ensuring timely drug dosage which are aiding in the global wearable patches market growth.
However, huge gap in the new product launches of wearable patches coupled with intricate process for approval by government authorities is expected to hinder the global wearable patches market growth.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Wearable Patches Market"
https://www.techsciresearch.com/report/wearable-patches-market/7324.html
Global wearable patches market has been segmented based on technology, application, end user, region, and company. Based on regional analysis, market is further divided into North America, South America, Asia Pacific, Europe and Middle East and Africa. North America is expected to dominate the global wearable patches market owing to the huge investments in addition to the presence of the significant players for the market growth. Also, Asia Pacific is expected to witness substantial growth in the forecast period owing to rise in the disposable income among middle class families and affordability for quality treatment is expected to foster the global wearable patches market growth.
Based on end user market is segmented into healthcare and fitness and sports. Consumers are becoming more concerned regarding their health and fitness. To constantly monitor health and keep track of calorie using diet applications is aiding in the increase of the demand for fitness and sports related wearable patches. Also, connectivity of patches through mobile phones and real-time analysis fosters the surge in the demand for the global wearable patches market.
Some of the leading players in global wearable patches market are Ramsay Health Care, Fortis Healthcare Limited, Community Health Systems, Inc., Spire Healthcare Group plc, Tenet Healthcare Corporation, Universal Health Services, Inc., IHH Healthcare Berhad, Apollo wearable patchess Enterprise Limited, HCA Healthcare, Fresenius SE (Helios and Vamed), ORPEA Group, Netcare, Mayo Clinic, Aster DM Healthcare Limited, China Resources Phoenix Healthcare Holdings Company Limited. In order to expand their market share, the companies adopt new product launches, collaborations, conduction of periodic sales and many more strategies. The growth of the global wearable patches market owing to increase in the affordability of wearable patches services coupled with surge in the chronic diseases is aiding global wearable patches market growth which is anticipated to increase the competition amongst key players and give out more positive outcomes.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7324
Customers can also request for 10% free customization on this report.
“Proliferation of internet services along with usage of wireless technology for enhanced connectivity is increasing the demand for the wearable patches market. Wearable patches keep track and monitor physical activities and give recommendations comparable to fitness devices and smart watches. Also, the flexibility of using wearable patches owing to advantage of not restraining body movements is expected to drive the global wearable patches market until 2026,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Wearable Patches Market, By Technology (Connected v/s Regular), By Application (Monitoring, Drug Delivery, Diagnostics, Others), By End User (Healthcare v/s Fitness & Sports), By Company, By Region (North America, South America, Asia Pacific, Middle East & Africa, Europe), Forecast & Opportunities, 2026”, has evaluated the future growth potential of global wearable patches market and provided statistics & information on market size, shares, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global wearable patches market.
Browse Related Reports:
Global Medical Electronics Market By Product Type (Therapeutic and Diagnostics), By End-user (Hospital, Ambulatory Surgical Center, Clinic & Others), By Region (North America, Europe, Asia-Pacific & Others), Competition, Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/medical-electronics-market/3896.html
Global Biochip Market By Type (DNA Chips, Lab-On-a-Chips & Protein Chips), By Technology (Microarray v/s Microfluidics), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others), By Company, By Region, Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/global-biochip-market/1259.html
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
#TechSci#Market Research Reports#Wearable Patches Market#Global Wearable Patches Market#Wearable Patches Market Size#Wearable Patches Market Forecast#Healthcare#healthcare reports
0 notes